Diagnostic Testing for Pertussis
The CDC recommends collecting a nasopharyngeal aspirate or Dacron swab for culture as the gold standard diagnostic test, with PCR endorsed as an additional option when the clinical case definition is met (cough >2 weeks with paroxysms, inspiratory "whoop," or post-tussive vomiting). 1
Clinical Case Definition
Before ordering diagnostic tests, confirm the patient meets clinical criteria:
- Acute cough persisting >2 weeks accompanied by at least one of the following: 2, 1
- Paroxysms of coughing
- Post-tussive vomiting
- Inspiratory whooping sound
Diagnostic Testing Algorithm
First-Line Testing: Culture
- Collect nasopharyngeal aspirate or use a Dacron swab (not cotton) of the nasopharynx for culture 2, 1
- Culture is 100% specific and remains the only certain way to make a definitive diagnosis 2, 1
- Critical limitation: sensitivity is only 30-60% in practice and drops to 1-3% after 3 weeks of cough 1
- Sensitivity decreases with: 1
- Duration >2 weeks of cough
- Prior antimicrobial treatment
- Previous pertussis vaccination
- Culture requires 1-2 weeks for definitive results 1
- Despite limitations, culture remains essential for antimicrobial susceptibility testing and molecular subtyping 1
PCR Testing
- The CDC endorses PCR only when the clinical case definition is also met (>2 weeks cough with characteristic features) 1
- PCR has significantly higher sensitivity (80-100%) compared to culture 2, 1
- PCR is 2-3 times more likely than culture to detect B. pertussis when classic symptoms are present 1
- PCR provides shorter turnaround time than culture 1
- Important caveat: The 2006 ACCP guidelines rated PCR as grade I (conflicting benefit) due to lack of standardized, validated techniques at that time 2, but the CDC now endorses PCR when clinical criteria are met 1
- PCR remains positive 1-7 days longer than culture after starting erythromycin treatment 3
Timing Considerations
- Begin testing as early as possible in the illness course 1
- Optimal window: within first 2-3 weeks of cough onset 2, 1
- After 3 weeks, culture sensitivity drops dramatically to 1-3% 1
- PCR maintains better sensitivity than culture in later stages 4, 5
Serologic Testing (Not Recommended for Routine Diagnosis)
- The CDC does not endorse single-sample serologic testing for routine diagnostic use 6
- Serology cannot differentiate between recent infection, remote infection, or vaccination response 6
- No FDA-licensed serologic assays exist for routine pertussis diagnosis in the United States 6
- If serology is used, paired sera (acute and convalescent) showing fourfold rise in IgG or IgA antibodies to pertussis toxin or filamentous hemagglutinin can confirm infection retrospectively 2, 6
- First sample should be taken within 2 weeks of cough onset, second sample 3-4 weeks later 2
- Paired sera have 99% specificity but only 63% sensitivity 2
Confirmed Diagnosis Criteria
A confirmed case requires one of the following: 2, 1
- Isolation of B. pertussis from nasopharyngeal culture, OR
- Clinical case with PCR confirmation, OR
- Clinical case with epidemiologic linkage to a confirmed case
Critical Treatment Considerations
- Do not delay treatment while awaiting test results 1
- Early treatment (within first 2 weeks) will rapidly clear B. pertussis from the nasopharynx and decrease coughing paroxysms 1
- Isolate patients for 5 days after starting antibiotic therapy 1
- Recommended treatment: erythromycin 40-50 mg/kg/day in children, 1-2 g/day in adults for 2 weeks 2
Common Pitfalls to Avoid
- Avoid relying solely on culture after 2-3 weeks of symptoms - sensitivity becomes extremely poor 1
- Do not use cotton swabs - use Dacron or polyester swabs for optimal specimen collection 2
- Do not order single-sample serology for acute diagnosis - it cannot distinguish infection from vaccination 6
- Do not wait for test results to initiate treatment in clinically suspected cases 1
- Avoid PCR testing in patients who don't meet clinical criteria - CDC endorses PCR only when clinical case definition is met 1